CERA wins Bupa Health Foundation Award
The Centre for Eye Research (CERA) has been awarded a significant Bupa Health Foundation grant in the 2012 Health Awards. This award will be used to fund further trials of a nanosecond laser to prevent vision loss from age-related macular degeneration (AMD).
This study will be the first in the world to investigate whether an Australian developed nanosecond laser technology can be used to successfully slow, or even reverse, the progression of AMD in its early stages.
AMD is the leading cause of vision loss in Australia and is increasing as the population ages. While there are treatments available for some forms of the advanced disease, there is no cure and no specific treatment to prevent early disease from progressing to the advanced forms.
The award was presented to CERA’s Head of Macular Research, Professor Robyn Guymer. Professor Guymer said she was delighted to receive the award and stressed how critical this funding would be to the continued success of the trial.
“The Bupa grant will enable us to undertake this study in several sites and conduct more detailed testing than was going to be possible before this funding became available,” said Professor Guymer.
“Bupa Health Foundation invests in initiatives and partners that have the potential to make a real difference to improving Australian health and healthcare. This support means that great ideas are turned into real action,” said Dr Christine Bennett, Chair of the Bupa Health Foundation Steering Committee.